600566: Hubei Jumpcan Pharmaceutical Co., Ltd. - Summary | Jitta

Hubei Jumpcan Pharmaceutical Co., Ltd.

CHN:600566

Price
CN¥24.51
Loss Chance
47.5%
5.53JITTA SCORE
77.97%Over Jitta Line
Jitta Ranking
188 / 486
1,900 / 5,270
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (39)
Recent Business Performance (63)
Financial Strength (80)
Return to Shareholders (62)
Competitive Advantage (60)
Jitta Signs
Operating MarginExpansion
Debt LevelLow Long Term Debt
CapExVery Low
Interest Coverage RatioVery Good
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Revenue and EarningRevenue decline from 2022-2025
Recent Business PerformanceEarning decline 27.00% in the last year
Key Stats
Jitta Score
Jitta Line
5.53
77.97%
4.40
> 1,000%
4.23
> 1,000%
Pharmaceuticals
7.55
2.58%
5.63
16.32%
7.34
27.35%
COMPANY DESCRIPTION
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.